RAPAd®

    The RAPAd® method of Adenovirus construction, developed by ViraQuest Inc. scientists, has been used by other scientists around the world.

    Request Quote

    Confidentiality

     

    Learn More

    Quality Control

    Plaque forming units guarantee. Non-detectable RCA.

    Learn More

    Turnaround Time

    Sub-cloning to finished particles in about four weeks.

    Learn More

    Dual Expressers

    Multiple transgene expression in a single virus.

    Learn More

Category Archives: Uncategorized

Methods and kits for treating disease by administering insulin-like growth factor binding protein-2

Authors: Jeffrey Friedman, Kristina Hedbacker
Citation: Patent Application

read more

Nonreplicating vaccines can protect african green monkeys from the memphis 37 strain of respiratory syncytial virus

Authors: Eyles JE, Johnson JE, Megati S, Roopchand V, Cockle PJ, Weeratna R, Makinen S, Brown TP, Lang S, Witko SE, Kotash CS, Li J, West K, Maldonado O, Falconer DJ, Lees C, Smith GJ, White P, Wright P, Loudon PT, Merson JR, Jansen KU, Sidhu MK
Citation: J Infect Dis. 2013 Jul 15;208(2):319-29

read more

Targets for treatment of hypercholesterolemia

Authors: Peter J. Tontonoz, Noam Zelcer
Citation: Patent Application

read more

Genetically Modified Macrophages and Renal Regeneration

Authors: Mastora, Chrysoula
Citation: Dissertation

read more

Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8+ T cells

Authors: Susan L. Baldwin, Lance K. Ching, Samuel O. Pine, Magdalini Moutaftsi, Elyse Lucas, Aarthy Vallur, Mark T. Orr, Sylvie Bertholet, Steven G. Reed and Rhea N. Coler
Citation: J Immunol September 1, 2013, 191 (5) 2514-2525

read more